Published in J Natl Cancer Inst on August 18, 1993
Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci (2009) 2.02
Exercise training as a treatment for chronic inflammation in the elderly. Exerc Sport Sci Rev (2009) 1.59
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br J Cancer (2000) 1.31
Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction. Mech Ageing Dev (2009) 1.14
Death receptor-associated pro-apoptotic signaling in aged skeletal muscle. Apoptosis (2006) 1.05
Protein degradation and increased mRNAs encoding proteins of the ubiquitin-proteasome proteolytic pathway in BC3H1 myocytes require an interaction between glucocorticoids and acidification. Proc Natl Acad Sci U S A (1996) 1.01
Multiple pathways to the same end: mechanisms of myonuclear apoptosis in sarcopenia of aging. ScientificWorldJournal (2010) 0.90
LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment. J Proteome Res (2014) 0.86
Nonmuscle Tissues Contribution to Cancer Cachexia. Mediators Inflamm (2015) 0.79
Effect of tea polyphenol on oxidative injury in S180 cells induced hepatocarcinoma mice. Int J Mol Sci (2012) 0.75
Frailty in Pulmonary and Critical Care Medicine. Ann Am Thorac Soc (2016) 0.75
Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.30
LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. Blood (2000) 1.64
Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest (1993) 1.53
Short-term effects of carbon dioxide on carnation callus cell respiration. Plant Physiol (1991) 1.34
Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem (1993) 1.33
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br J Cancer (2000) 1.31
Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J (2003) 1.27
Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun (1999) 1.23
TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun (1997) 1.17
Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett (1994) 1.15
Metabolic effects of tumour necrosis factor-alpha (cachectin) and interleukin-1. Clin Sci (Lond) (1989) 1.15
Tumour necrosis factor-alpha increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett (1993) 1.13
The metabolic basis of cancer cachexia. Med Res Rev (1997) 1.10
Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. J Clin Invest (1995) 1.09
Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer (2009) 1.09
The role of cytokines in cancer cachexia. Med Res Rev (1999) 1.08
Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice. Mol Cell Endocrinol (1998) 1.07
Direct effects of doxorubicin on skeletal muscle contribute to fatigue. Br J Cancer (2009) 1.02
Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim Biophys Acta (2001) 1.02
Muscle wasting in cancer and ageing: cachexia versus sarcopenia. Adv Gerontol (2006) 1.01
Ubiquitin gene expression in skeletal muscle is increased by tumour necrosis factor-alpha. Biochem Biophys Res Commun (1994) 1.01
Insulin and cancer (Review). Int J Oncol (2001) 1.00
Ubiquitin gene expression in skeletal muscle is increased during sepsis: involvement of TNF-alpha but not IL-1. Biochem Biophys Res Commun (1995) 0.99
Amino acid metabolism in tumour-bearing mice. Biochem J (1988) 0.97
Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett (1998) 0.97
Why do cancer cells have such a high glycolytic rate? Med Hypotheses (1990) 0.97
TNF-alpha is involved in activating DNA fragmentation in skeletal muscle. Br J Cancer (2002) 0.97
Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1. Cancer Lett (1998) 0.97
Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody. Cell Death Differ (2003) 0.96
DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia? Biochem Biophys Res Commun (2000) 0.96
Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model. Cancer Lett (2001) 0.94
Journey from cachexia to obesity by TNF. FASEB J (1997) 0.93
The ubiquitin-dependent proteolytic pathway in skeletal muscle: its role in pathological states. Trends Pharmacol Sci (1996) 0.93
Cancer cachexia: a therapeutic approach. Med Res Rev (2001) 0.93
TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. Int J Obes Relat Metab Disord (2002) 0.92
Cytokines and diabetes: the final step? Involvement of TNF-alpha in both type I and II diabetes mellitus. Horm Metab Res (1994) 0.90
Skeletal muscle UCP2 and UCP3 gene expression in a rat cancer cachexia model. FEBS Lett (1998) 0.90
Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia. Br J Cancer (2008) 0.88
Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation. Int J Oncol (2005) 0.87
Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats. Biochem Biophys Res Commun (1996) 0.87
Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin Sci (Lond) (1994) 0.86
TNF and pregnancy: the paradigm of a complex interaction. Cytokine Growth Factor Rev (1997) 0.86
Catabolic proinflammatory cytokines. Curr Opin Clin Nutr Metab Care (1998) 0.86
Branched-chain amino acids inhibit proteolysis in rat skeletal muscle: mechanisms involved. J Cell Physiol (2000) 0.85
Intestinal handling of a glucose gavage by the rat. Mol Cell Biochem (1992) 0.85
The role of cytokines in muscle wasting: its relation with cancer cachexia. Med Res Rev (1992) 0.85
Calpain-3 gene expression is decreased during experimental cancer cachexia. Biochim Biophys Acta (2000) 0.85
The energy state of tumor-bearing rats. J Biol Chem (1991) 0.85
Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth. Cancer Lett (1997) 0.85
Direct effects of tumor necrosis factor alpha (TNF-alpha) on murine skeletal muscle cell lines. Bimodal effects on protein metabolism. Eur Cytokine Netw (2001) 0.85
Administration of tumor necrosis factor-alpha results in a decreased placental transfer of amino acids in the rat. Endocrinology (1995) 0.85
Increased uncoupling protein-2 gene expression in brain of lipopolysaccharide-injected mice: role of tumour necrosis factor-alpha? Biochim Biophys Acta (2001) 0.85
Prevention of cancer and cardiovascular diseases: a common strategy? Med Res Rev (1998) 0.84
Leptin and tumor growth in rats. Int J Cancer (1999) 0.84
[Pathophysiology of neoplasic cachexia]. Nutr Hosp (2006) 0.84
Sequential changes in lipoprotein lipase activity and lipaemia induced by the Yoshida AH-130 ascites hepatoma in rats. Cancer Lett (1997) 0.84
The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting. Eur Cytokine Netw (2000) 0.83
Lipid metabolism in tumour-bearing mice: studies with knockout mice for tumour necrosis factor receptor 1 protein. Mol Cell Endocrinol (1997) 0.83
In the rat, intestinal lymph carries a significant amount of ingested glucose into the bloodstream. Arch Int Physiol Biochim Biophys (1992) 0.82
Lipids: A key role in multidrug resistance? (Review). Int J Oncol (2000) 0.82
Circadian changes in glycogen content in rat interscapular brown adipose tissue: effect of cold exposure and food deprivation. Biochem Int (1990) 0.82
Interleukin-6 does not activate protein breakdown in rat skeletal muscle. Cancer Lett (1994) 0.82
Gas chromatographic method for the estimation of acetone and its metabolites in biological samples. J Chromatogr (1987) 0.82
Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486. Cancer Lett (1996) 0.81
In the rat, tumor necrosis factor alpha administration results in an increase in both UCP2 and UCP3 mRNAs in skeletal muscle: a possible mechanism for cytokine-induced thermogenesis? FEBS Lett (1998) 0.81
The increased skeletal muscle protein turnover of the streptozotocin diabetic rat is associated with high concentrations of branched-chain amino acids. Biochem Mol Med (1997) 0.81
Mechanism for the increased skeletal muscle protein degradation in the obese Zucker rat. J Nutr Biochem (1999) 0.81
Anti-TNF treatment does not reverse the abnormalities in lipid metabolism of the obese Zucker rat. Am J Physiol (1997) 0.81
The effects of tumour necrosis factor-alpha (cachectin) and tumour growth on hepatic amino acid utilization in the rat. Biochem J (1990) 0.81